Abiopharma

🔍 Larson Barbara A (Director)

Company: EQUIFAX INC (EFX)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 181 shares of Phantom Stock Units (Derivative)
  Date: 2026-08-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 181.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Acquired 160 shares of Phantom Stock Units (Derivative)
  Date: 2026-08-10 | Code: A | equity_swap_involved: 0 | shares_owned_after: 341.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1

Footnotes:

• F1: Represents phantom stock units previously elected by the reporting person to be received as deferred compensation in lieu of annual cash retainer fees under the Company's Board of Directors Deferred Compensation Plan. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable, at the election of the reporting person, upon the reporting person's termination of service as a director.